Mohammad Ameen Ishqair: Blood Group Antigens as Emerging Biomarkers in Disease
Mohammad Ameen Ishqair, General and Emergency Physician at Al Madina Medical Center, shared on LinkedIn:
“I am honored to share that our research chapter, ‘Blood Group Antigens as Disease Markers: Infectious, Autoimmune and Neoplastic Associations’, has just been published Open Access with IntechOpen.
This work, co-authored with my exceptional research group: Dr. Aliaa Khalili, Dr. Amal Abo-Jheasha, and Dr. Anas Ameen, explores how blood group antigens extend beyond transfusion medicine to serve as critical biomarkers in infectious, autoimmune, and neoplastic diseases.
We integrate genomic data, molecular mechanisms, and epidemiological insights to provide a comprehensive paradigm for clinicians and researchers.
Read the full chapter on IntechOpen.”
Stay updated on all scientific advances with Hemostasis Today.
-
May 25, 2026, 13:04Dhruvi Joshi: Reduced-Dose DOAC Therapy in Patients With Venous Thromboembolism
-
May 25, 2026, 13:04Luke McLaughlin: Haemophilia Care as a Matter of Global Health Equity
-
May 25, 2026, 12:33Laird Bruce de Graaf: The Most Compassionate Gift You Can Give
-
May 25, 2026, 12:30Dheri Lubis: Deeper Into Immunohematology Beyond Basic Blood Grouping
-
May 25, 2026, 11:20Abdul Mannan: Why Thalassaemia Is More Than Low Haemoglobin
-
May 25, 2026, 11:06Roberta Gualtierotti: Iron Is More Than a Hematologic Parameter
-
May 25, 2026, 11:03Divyaswathi Citla Sridhar: How Bone Health Is Impacted in Bleeding Disorders
-
May 25, 2026, 10:48Ama Ameyaw: Beginning My Research Journey in HIT and Platelet Immunology at the Wen Lab
-
May 25, 2026, 10:46Fredrick Chalinga: Negative DAT Does Not Mean No Hemolysis